{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-004863","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2026-07-24T15:58:37+00:00","discovered_at":"2026-07-24T16:03:00.469989+00:00","generated_at":"2026-07-24T16:03:04.118476+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CAPTAIN trial: TULSA preserves penile length vs 0.65 cm loss with robotic RP at 1 month","bullets":["No median change in penile length at 1 month for TULSA vs 0.65 cm reduction for robotic RP.","Between-arm difference in penile length change was 0.42 cm (p<0.001), statistically significant.","TULSA previously showed statistically significant superiority over robotic RP in erectile function and urinary continence at 6 months.","Data presented at Society of Robotic Surgery Annual Meeting by Dr. Xiaosong Meng of UT Southwestern."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-004863","json":"https://secwatch.observer/filing/0001171843-26-004863.json","markdown":"https://secwatch.observer/filing/0001171843-26-004863.md","text":"https://secwatch.observer/filing/0001171843-26-004863.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326004863/0001171843-26-004863-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326004863/f8k_072426.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-24T16:03:04.118476+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}